Rxivist logo

HNF1A is a Novel Oncogene and Central Regulator of Pancreatic Cancer Stem Cells

By Ethan V. Abel, Masashi Goto, Brian Magnuson, Saji Abraham, Nikita Ramanathan, Emily Hotaling, Anthony A. Alaniz, Chandan Kumar-Sinha, Michele L. Dziubinski, Sumithra Urs, Lidong Wang, Jiaqi Shi, Meghna Waghray, Mats Ljungman, Howard C. Crawford, Diane M. Simeone

Posted 22 Dec 2017
bioRxiv DOI: 10.1101/238097 (published DOI: 10.7554/elife.33947)

The biological properties of pancreatic cancer stem cells (PCSCs) remain incompletely defined and the central regulators are unknown. By bioinformatic analysis of a PCSC-enriched gene signature, we identified the transcription factor HNF1A as a putative central regulator of PCSC function. Levels of HNF1A and its target genes were found to be elevated in PCSCs and tumorspheres, and depletion of HNF1A resulted in growth inhibition, apoptosis, impaired tumorsphere formation, PCSC depletion, and downregulation of OCT4 expression. Conversely, HNF1A overexpression increased PCSC numbers and tumorsphere formation in pancreatic cancer cells and drove PDA cell growth. Importantly, depletion of HNF1A in primary tumor xenografts impaired tumor growth and depleted PCSCs in vivo. Finally, we established an HNF1A-dependent gene signature in PDA cells that significantly correlated with reduced survivability in patients. These findings identify HNF1A as a central transcriptional regulator of the PCSC state and novel oncogene in pancreatic ductal adenocarcinoma.

Download data

  • Downloaded 760 times
  • Download rankings, all-time:
    • Site-wide: 35,097
    • In cancer biology: 931
  • Year to date:
    • Site-wide: 105,299
  • Since beginning of last month:
    • Site-wide: 85,301

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide